Kelsey Carter Selected Research

N- fluoroacetyl- N- (2,5- dimethoxybenzyl)- 2- phenoxyaniline

2/2021

Widespread Glial Activation in Primary Progressive Multiple Sclerosis Revealed by 18F-PBR06 PET: A Clinically Feasible, Individualized Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kelsey Carter Research Topics

Disease

6	Neoplasms (Cancer) 02/2022 - 01/2016
4	Ovarian Neoplasms (Ovarian Cancer) 08/2020 - 01/2016
3	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Autoimmune Diseases of the Nervous System 01/2022
1	COVID-19 11/2021
1	Chronic Progressive Multiple Sclerosis 02/2021
1	Meningitis 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

3	withaferin AIBA 08/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2021
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2016
2	verrucarin JIBA 01/2019 - 11/2017
2	PlatinumIBA 09/2017 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 01/2016
1	Hematoxylin (Haematoxylon)IBA 02/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Disinfectants (Biocides)IBA 11/2021
1	N- fluoroacetyl- N- (2,5- dimethoxybenzyl)- 2- phenoxyanilineIBA 02/2021
1	LigandsIBA 02/2021
1	ocrelizumabIBA 01/2021
1	CateninsIBA 01/2019
1	SecurinIBA 11/2017
1	taxaneIBA 09/2017
1	Aldehyde DehydrogenaseIBA 09/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	liposomal doxorubicin (Doxil)FDA Link 01/2016
1	Staphylococcal Protein A (Protein A)IBA 01/2016

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 09/2017 - 01/2016
1	Immunotherapy 01/2022
1	Cytoreduction Surgical Procedures 01/2016
1	Therapeutics 01/2016